 Telangiectasia, Hereditary Hemorrhagic
"Telangiectasia, Hereditary Hemorrhagic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.
| Descriptor ID |
D013683
|
| MeSH Number(s) |
C14.907.454.900 C14.907.823.780 C15.378.463.515.900 C16.131.240.850.968
|
| Concept/Terms |
Telangiectasia, Hereditary Hemorrhagic- Telangiectasia, Hereditary Hemorrhagic
- Hemorrhagic Telangiectasia, Hereditary
- Rendu-Osler-Weber
- Rendu Osler Weber
- Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber
- Telangiectasia, Hereditary Hemorrhagic, Type 1
- Osler-Rendu Disease
- Osler Rendu Disease
- Osler-Rendu-Weber Disease
- Osler Rendu Weber Disease
- Hereditary Hemorrhagic Telangiectasia
- Osler's Disease
- Disease, Osler's
- Osler Disease
- Osler-Weber-Rendu Syndrome
- Osler Weber Rendu Syndrome
- Weber-Osler
- Weber Osler
|
Below are MeSH descriptors whose meaning is more general than "Telangiectasia, Hereditary Hemorrhagic".
Below are MeSH descriptors whose meaning is more specific than "Telangiectasia, Hereditary Hemorrhagic".
This graph shows the total number of publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in this website by year, and whether "Telangiectasia, Hereditary Hemorrhagic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2011 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2022 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Telangiectasia, Hereditary Hemorrhagic" by people in Profiles.
-
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2022 06 01; 117(6):846-864.
-
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ. Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2022 06; 95(6):1025-1047.
-
Boland CR, Idos GE, Durno C, Giardiello FM, Anderson JC, Burke CA, Dominitz JA, Gross S, Gupta S, Jacobson BC, Patel SG, Shaukat A, Syngal S, Robertson DJ. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2022 06; 162(7):2063-2085.
-
Khanwalkar AR, Rathor A, Read AK, Paknezhad H, Ma Y, Hwang PH. Randomized, controlled, double-blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization. Int Forum Allergy Rhinol. 2022 08; 12(8):1034-1042.
-
Murray E, Taylor J, Hountras P. A Case of High-Output Heart Failure. Chest. 2022 01; 161(1):e23-e28.
-
Faughnan ME, Mager JJ, Hetts SW, Palda VA, Lang-Robertson K, Buscarini E, Deslandres E, Kasthuri RS, Lausman A, Poetker D, Ratjen F, Chesnutt MS, Clancy M, Whitehead KJ, Al-Samkari H, Chakinala M, Conrad M, Cortes D, Crocione C, Darling J, de Gussem E, Derksen C, Dupuis-Girod S, Foy P, Geisthoff U, Gossage JR, Hammill A, Heimdal K, Henderson K, Iyer VN, Kjeldsen AD, Komiyama M, Korenblatt K, McDonald J, McMahon J, McWilliams J, Meek ME, Mei-Zahav M, Olitsky S, Palmer S, Pantalone R, Piccirillo JF, Plahn B, Porteous MEM, Post MC, Radovanovic I, Rochon PJ, Rodriguez-Lopez J, Sabba C, Serra M, Shovlin C, Sprecher D, White AJ, Winship I, Zarrabeitia R. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med. 2020 12 15; 173(12):989-1001.
-
Albitar HAH, Almodallal Y, Gallo De Moraes A, O'Brien E, Choby GW, Pruthi RK, Stokken JK, Kamath PS, Cajigas HR, DuBrock HM, Krowka MJ, Iyer VN. Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy. Mayo Clin Proc. 2020 08; 95(8):1604-1612.
-
Vella M, Alexander MD, Mabray MC, Cooke DL, Amans MR, Glastonbury CM, Kim H, Wilson MW, Langston DE, Conrad MB, Hetts SW. Comparison of MRI, MRA, and DSA for Detection of Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia. AJNR Am J Neuroradiol. 2020 06; 41(6):969-975.
-
Iyer VN, Saberi B, Heimbach JK, Larson JJ, Raghavaiah S, Ditah I, Swanson K, Kamath PS, Watt KD, Taner T, Krowka MJ, Leise MD. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States. Transplantation. 2019 07; 103(7):1418-1424.
-
Krishnan S, Lahm T. A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations. Medicine (Baltimore). 2018 Aug; 97(32):e11513.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|